THE TRANSFORMATION OF THE CLINICAL TRIAL SERVICES SUPPLY CHAIN – ARE YOU LABEL READY?

THE TRANSFORMATION OF THE CLINICAL TRIAL SERVICES SUPPLY CHAIN – ARE YOU LABEL READY?

HOW LABEL DESIGN AND CONTENT MANAGEMENT SERVICES ARE HELPING CLINICAL SERVICE PROVIDERS ADD GREATER VALUE

In recent years, clinical service provider organizations have had to reinvent themselves to keep up with a continually growing and fast-changing industry. COVID-19, decentralization, growth of biologics, and adaptive trials have all put pressure on the traditional outsourced supply chain. Forward-thinking pharma sponsors and clinical service providers are collaborating closely and exploring new ways to bring drugs and medical products to market.

To work more effectively and bring investigational products to trial faster, the need for outsourcing has seen a surge globally. This inevitably brings new challenges and complexities around label management with multiple parties involved.

Now more than ever, content and label management is a crucial part of the clinical trial contract supplies chain. If something is labeled incorrectly, the chain breaks, leading to trial delays, non-compliance to regulations and most importantly putting patients at risk. In particular, delays with obtaining production-ready labels can be an unfortunate occurrence that can postpone trial start with significant financial burden.

As clinical research evolves, so must the labeling technologies, processes and services in order to meet these new demands. By utilizing cloud-based label design and content management applications, clinical service providers’ operations can be streamlined, giving the ability to support different production and supply models, as well as evolve service offerings, thereby gaining competitive edge.

March 2022 Webinar 768x401 - THE TRANSFORMATION OF THE CLINICAL TRIAL SERVICES SUPPLY CHAIN – ARE YOU LABEL READY?

Key Learning Objectives:

  • Understand how changes in clinical research are driving transformation within the clinical trial supply chain
  • Learn how this shift is driving clinical research outsourcers and service providers to expand their service offerings, labeling design and content services including:
    • Booklet Design Services
    • Translation Services
    • Randomization Services
  • Discover how service providers are meeting new supply models, such as ‘direct to patient’, utilizing Just In Time (JIT) production
  • See how clinical trial-specific labeling applications are being used by service providers to become a more valued partner for sponsors, by being more agile and flexible

Audience

  • Clinical Research Organizations (CRO)
  • Clinical Development & Manufacturing Organizations (CDMO)
  • Clinical Supplies Organization (CSO)
  • Pharmaceutical R&D

MEET THE PANEL

PRISYM ID makes new senior appointment to drive further growth in clinical trials arena  - THE TRANSFORMATION OF THE CLINICAL TRIAL SERVICES SUPPLY CHAIN – ARE YOU LABEL READY?

Bob Bowdish

Director of Clinical Trial Sales North America at PRISYM ID

Bob Bowdish is Director of Clinical Trail Sales North America at PRISYM ID. He has over 25 years’ experience in the life sciences in commercial and research development. His last five years has been helping life science companies leverage regulatory and clinical software to realize efficiencies that result in delivering treatments to the patients they serve.

Bob’s diverse healthcare experience gives him the insight on how regulatory and clinical data can contribute to commercial success. This insight has proven to deliver innovative software solutions that have shortened time to market and enhanced patient safety.

linkedin 36x36 - THE TRANSFORMATION OF THE CLINICAL TRIAL SERVICES SUPPLY CHAIN – ARE YOU LABEL READY?

Simon Jones small e1644585274912 - THE TRANSFORMATION OF THE CLINICAL TRIAL SERVICES SUPPLY CHAIN – ARE YOU LABEL READY?

Simon Jones

VP of Global Products, PRISYM ID

Simon Jones is VP of Global Products for PRISYM ID with responsibility for managing the end-to-end lifecycle of the company’s regulated content and label management product portfolio.

Simon has 20 years of experience in delivering product strategies and product positioning which address market opportunities effectively. He is a subject matter expert in medical device and clinical trial labeling space, researching this market, identifying industry challenges, investigating market trends, and identifying where the industry is going from a technology and regulatory perspective.

linkedin 36x36 - THE TRANSFORMATION OF THE CLINICAL TRIAL SERVICES SUPPLY CHAIN – ARE YOU LABEL READY?